Discovery of seven-membered ring berberine analogues as highly potent and specific hCES2A inhibitors
文献类型:期刊论文
作者 | Yang, Yun2,3; Xiong, Yuan2; Zhu, Guanghao2; Sun, Mengru2; Zou, Kun2; Zhao, Yitian2; Zhang, Yong3; Xu, Zhijian1,3; Li, Yiming2; Zhu, Weiliang1,3 |
刊名 | CHEMICO-BIOLOGICAL INTERACTIONS |
出版日期 | 2023-06-01 |
卷号 | 378页码:11 |
ISSN号 | 0009-2797 |
关键词 | Human carboxylesterase 2 (hCES2A) Berberine analogues Structure -activity relationships (SAR) Inhibition kinetics Selectivity |
DOI | 10.1016/j.cbi.2023.110501 |
通讯作者 | Jia, Qi(q_jia@126.com) ; Li, Bo(boli@simm.ac.cn) ; Ge, Guangbo(geguangbo@shutcm.edu.cn) |
英文摘要 | Human carboxylesterase 2A (hCES2A) is a key serine hydrolase responsible for the metabolic clearance of large number of compounds bearing the ester- or amide-bond(s). Inhibition of hCES2A can relieve the chemotherapyinduced toxicity and alter the pharmacokinetic bahaviors of some orally administrate esters-containing agents. However, most of the hCES2A inhibitors show poor cell-membrane permeability and poor specificity. Herein, guided by the structure activity relationships (SAR) of fifteen natural alkaloids against hCES2A, fifteen new seven-membered ring berberine analogues were designed and synthesized, and their anti-hCES2A activities were evaluated. Among all tested compounds, compound 28 showed potent anti-hCES2A effect (IC50 = 1.66 mu M) and excellent selectivity over hCES1A (IC50 > 100 mu M). The SAR analysis revealed that the seven-membered ring of these berberine analogues was a crucial moiety for hCES2A inhibition, while the secondary amine group of the ring-C is important for improving their specificity over other serine hydrolases. Inhibition kinetic analyses and molecular dynamic simulation demonstrated that 28 strongly inhibited hCES2A in a mixed-inhibition manner, with an estimated Ki value of 1.035 mu M. Moreover, 28 could inhibit intracellular hCES2A in living HepG2 cells and exhibited suitable metabolic stability. Collectively, the SAR of seven-membered ring berberine analogues as hCES2A inhibitors were studied, while compound 28 acted as a promising candidate for developing highly selective hCES2A inhibitors. |
WOS关键词 | HUMAN CARBOXYLESTERASES ; CATALYTIC-PROPERTIES ; SENSITIVE DETECTION ; FLUORESCENT-PROBE ; SUBSTRATE ; CHEMOTHERAPY ; ACTIVATION ; IRINOTECAN ; ISOZYMES ; ACCURACY |
资助项目 | Chinese Pharmaceutical Association-Yiling Biopharmaceutical Innovation Project[CPAYLJ201908] ; Natural Science Foundation of China[81922070] ; Natural Science Foundation of China[81973286] ; Natural Science Foundation of China[22277129] ; Innovation Team and Talents Cultivation Pro-gram of National Administration of Traditional Chinese Medicine[ZYYCXTD-D-202004] ; Three-year Action Plan for Shanghai TCM Development and Inheritance Program[ZY (2021-2023) -0401] |
WOS研究方向 | Biochemistry & Molecular Biology ; Pharmacology & Pharmacy ; Toxicology |
语种 | 英语 |
出版者 | ELSEVIER IRELAND LTD |
WOS记录号 | WOS:000984657000001 |
源URL | [http://119.78.100.183/handle/2S10ELR8/306526] |
专题 | 新药研究国家重点实验室 |
通讯作者 | Jia, Qi; Li, Bo; Ge, Guangbo |
作者单位 | 1.Univ Chinese Acad Sci, Sch Pharm, Beijing 100049, Peoples R China 2.Shanghai Univ Tradit Chinese Med, Inst Interdisciplinary Integrat Med Res, Shanghai Frontiers Sci Ctr TCM Chem Biol, Sch Pharm, Shanghai 201203, Peoples R China 3.Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, State Key Lab Drug Res, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China |
推荐引用方式 GB/T 7714 | Yang, Yun,Xiong, Yuan,Zhu, Guanghao,et al. Discovery of seven-membered ring berberine analogues as highly potent and specific hCES2A inhibitors[J]. CHEMICO-BIOLOGICAL INTERACTIONS,2023,378:11. |
APA | Yang, Yun.,Xiong, Yuan.,Zhu, Guanghao.,Sun, Mengru.,Zou, Kun.,...&Ge, Guangbo.(2023).Discovery of seven-membered ring berberine analogues as highly potent and specific hCES2A inhibitors.CHEMICO-BIOLOGICAL INTERACTIONS,378,11. |
MLA | Yang, Yun,et al."Discovery of seven-membered ring berberine analogues as highly potent and specific hCES2A inhibitors".CHEMICO-BIOLOGICAL INTERACTIONS 378(2023):11. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。